2025年全球免疫检测市场报告

近年来，免疫检测市场稳定成长，从2024年的358.1亿美元成长到2025年的373.2亿美元，复合年增长率为4.2%。预测期内的成长主要受疾病流行、人口老化、感染疾病爆发、就地检验、研究经费增加等因素所驱动。

预计未来几年免疫检测市场规模将强劲成长，到2029年将达到494亿美元，复合年增长率为7.3%。预测期内的成长可归因于个人化医疗、新兴市场的扩张、疫情防治、癌症诊断以及向居家检测的转变。预测期内的主要趋势包括监管协调、多用途免疫检测、客製化检测服务、与穿戴式装置的整合以及检测法的微型化。

免疫检测是一种生物分析测试，利用抗体与抗原的结合来检测和定量特定化学物质，在疾病诊断中发挥重要作用。免疫检测测试结果的资讯可用于制定适当的治疗策略。免疫检测测试依赖高特异性抗分析物抗体上有限数量的受体与大多数标记和未标记样本分析物之间的竞争性结合反应。

免疫检测产品的主要类型包括试剂和套件、分析仪和设备以及软体和服务。试剂是促进反应的物质或产品，常用于各种测试。免疫检测样本包括血液、唾液和尿液，检体包括治疗监测、肿瘤学、循环系统、内分泌学、传染病检查和自体免疫疾病。免疫检测产品的最终用户多种多样，包括研究和学术实验室、居家医疗机构、製药和生物技术公司、委外研发机构(CRO)、血库、医院和诊所以及临床实验室。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制价格上涨，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、加强标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供免疫检测市场统计数据，例如免疫检测行业的全球市场规模、各地区市场份额、免疫检测测定市场份额的竞争对手、详细的免疫检测市场细分、市场趋势和机会，以及您在免疫检测行业取得成功所需的数据。本免疫检测市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年7.3%的预测成长率比我们先前对该市场的预测略有下降，下降了0.2%。下降的主要原因是美国与其他国家之间关税的影响。美国可能会直接感受到这种影响，因为酵素连结抗体和微孔盘洗板机的供应链中断，这些产品来自瑞士和荷兰等主要地区，这可能导致传染病检查延迟和诊断实验室成本增加。此外，这种影响可能会透过互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，在更广泛的范围内显现。

感染疾病和慢性病的流行预计将在不久的将来推动免疫检测市场的成长。慢性病通常被定义为持续一年以上、需要持续治疗、限制日常活动或两者兼而有之的疾病。感染疾病是由细菌、病毒、真菌和寄生虫等生物引起的疾病。许多生物在人体内和人与人之间共存，有些感染疾病可以在人与人之间传播。免疫检测用于检测各种感染疾病和慢性病。例如，根据美国生物医学研究机构国立卫生研究院 (NIH) 的报告，预计到 2023 年，美国50 岁及以上患有至少一种慢性病的人数将增加 99.5%，从 2020 年的 71,522,000 人增加到 2050 年的 142,660,000 人。此外，患有多种疾病的人数预计将增加 91.16%，从 2020 年的 7,834,000 人增加到 2050 年的 14,968,000 人。因此，感染疾病和慢性病的日益普及正在推动市场的成长。

预计政府主导的医疗保健研究和开发倡议将在未来几年支持免疫检测市场的成长。这些措施是指各级政府当局（地方、区域、国家和国际）为解决具体问题、实现具体目标和带来计划积极变化而采取的具体行动、计划、措施和项目。这些倡议旨在改善诊断测试的可近性、提高医疗保健品质和应对公共卫生挑战，从而推动对免疫测量的需求。例如，2022 年，英国政府机构卫生和社会保障部宣布资助 2.6 亿英镑（2.7065 亿美元）加强医疗保健研究和製造。 BEIS 和 DHSC 的这项承诺旨在透过新的隐私保护平台和临床研究服务支持美国主导的诊断​​和治疗健康研究，并拨款 6,000 万英镑（6,360 万美元）支持英国生命科学製造业的扩张。因此，政府在医疗保健领域的倡议的成长正在推动免疫检测市场的发展。

产品创新是发展势头强劲的关键趋势，领先企业正努力透过提供尖端产品来巩固其市场地位。例如，中国生物技术公司Getein BIoTech Inc.在2022年德国慕尼黑国际医学展览会上推出了MAGICL 6000。这款可携式化学冷光免疫检测分析仪专为中高容量工作流程的实验室设计，提供一步式化学冷光解决方案。该设备以其高效、紧凑、全自动和快速评估频率而脱颖而出，为诊断实验室提供了一个技术先进的选择。

免疫检测市场包括供应免疫检测套件、分析仪和试剂的营业单位所获得的收益。市场规模还包括服务供应商销售或包含在其服务产品中的相关商品的价值。仅包括营业单位之间交易或销售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球免疫检测：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
• 最终用途产业分析
• 全球免疫检测市场：成长率分析
• 全球免疫检测市场表现：规模与成长，2019-2024
• 全球免疫检测市场预测：规模与成长，2024-2029 年，2034 年
• 全球免疫检测：总目标市场（TAM）

第六章 市场细分

• 全球免疫检测市场（按产品、性能和预测），2019-2024 年、2024-2029 年、2034 年
• 试剂和套件
• 分析设备和仪器
• 软体和服务
• 全球免疫检测市场（按样本类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
• 血
• 唾液
• 尿
• 其他的
• 全球免疫检测市场的应用、效能与预测，2019-2024 年、2024-2029 年、2034 年
• 治疗监测
• 肿瘤学
• 心臟病学
• 内分泌学
• 传染病检查
• 自体免疫疾病
• 其他的
• 全球免疫检测市场（按最终用户划分）：2019-2024 年、2024-2029 年、2034 年表现与预测
• 研究和学术实验室
• 居家照护
• 製药生物技术公司和合约研究组织 (CRO)
• 血库
• 医院和诊所
• 临床实验室
• 全球免疫检测市场：试剂和套件细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• ELISA套件
• 快速检测套组
• 对照试剂
• 分析开发试剂
• 医院和诊所
• 全球免疫检测市场：分析仪器和设备细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 自动分析仪
• 就地检验设备
• 微孔盘读数仪
• 光度计
• 全球免疫检测市场：软体和服务细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 资料管理软体
• 分析软体
• 支援和维护服务
• 咨询服务

第七章 区域和国家分析

• 全球免疫检测市场：2019-2024 年、2024-2029 年和 2034 年区域表现和预测
• 全球免疫检测市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

• 免疫检测市场：竞争格局
• 免疫检测市场：公司简介
  • Siemens Healthineers GmbH
  • bioMerieux
  • Abbott
  • Beckman Coulter Inc.
  • Quidel Corporation

第31章：其他领先和创新企业

• Ortho Clinical Diagnostics
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• Becton Dickinson and Company
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Agilent Technologies Inc.
• PerkinElmer Inc
• WAK-Chemie Medical GmbH
• J Mitra & Co Pvt Ltd
• Kamiya Biomedical Company
• Tosoh Corporation
• Gyros Protein Technologies AB
• BioCheck Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

• 2029年免疫检测市场：提供新机会的国家
• 2029年免疫检测市场：细分市场带来新机会
• 2029年免疫检测市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手策略

第36章 附录

Immunoassay is a bioanalytical test that utilizes the binding of antibodies to antigens to detect and quantify specific chemicals, playing a crucial role in the diagnosis of diseases. Information derived from immunoassay test results can be used to establish appropriate courses of therapy. This method relies on a competitive binding reaction between a limited number of receptors on a highly specific anti-analyte antibody, labeled versions of an analyte, and a significant portion of an unlabeled sample analyte.

The main types of immunoassay products include reagents and kits, analyzers or instruments, and software and services. Reagents are substances or products that accelerate a reaction and are commonly used in various tests. Immunoassay specimens include blood, saliva, urine, and others, and the technique is applied in therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease testing, autoimmune diseases, and more. The end users of immunoassay products are diverse and include research and academic laboratories, home care settings, pharmaceutical and biotechnology companies, Contract Research Organizations (CROs), blood banks, hospitals and clinics, and clinical laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The immunoassay market research report is one of a series of new reports from The Business Research Company that provides immunoassay market statistics, including immunoassay industry global market size, regional shares, competitors with a immunoassay market share, detailed immunoassay market segments, market trends and opportunities, and any further data you may need to thrive in the immunoassay industry. This immunoassay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunoassay market size has grown steadily in recent years. It will grow from $35.81 billion in 2024 to $37.32 billion in 2025 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to disease prevalence, aging population, infectious disease outbreaks, point-of-care testing, increased research funding.

The immunoassay market size is expected to see strong growth in the next few years. It will grow to $49.4 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to personalized medicine, expansion in emerging markets, pandemic preparedness, cancer diagnostics, shift to home-based testing. Major trends in the forecast period include regulatory harmonization efforts, multipurpose immunoassays, customized assay services, integration with wearable devices, and miniaturization of assays.

The forecast of 7.3% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for enzyme-conjugated antibodies and microplate washers, sourced from key regions such as Switzerland and the Netherlands, which could lead to slower infectious disease testing and increased diagnostic laboratory costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of infectious and chronic diseases is expected to drive the growth of the immunoassay market in the near future. Chronic illnesses are generally defined as conditions that last for a year or longer, require ongoing medical attention, restrict daily activities, or both. Infectious diseases are illnesses caused by organisms such as bacteria, viruses, fungi, or parasites. Numerous organisms coexist within and on the human body, and several infectious diseases can be transmitted from one person to another. Immunoassays are utilized to detect various infectious and chronic diseases. For example, a report from the National Institutes of Health (NIH), a US-based biomedical research agency, stated that in 2023, the number of individuals aged 50 and older in the United States with at least one chronic illness is projected to increase by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Moreover, the number of people with multimorbidity is expected to rise by 91.16%, from 7.8304 million in 2020 to 14.968 million by 2050. Therefore, the increasing incidence of infectious and chronic diseases is driving market growth.

Government-led research and development initiatives in healthcare are anticipated to support the growth of the immunoassay market in the future. These initiatives refer to specific actions, programs, policies, or projects undertaken by government authorities at various levels-local, regional, national, or international-to tackle specific issues, achieve certain objectives, or foster positive changes in society. Such initiatives have aimed at improving access to diagnostic testing, enhancing healthcare quality, and addressing public health challenges, thereby driving demand for immunoassays. For instance, in 2022, the Department of Health and Social Care, a UK government authority, announced £260 million (US$270.65 million) in funding to enhance healthcare research and manufacturing. This commitment, made by BEIS and DHSC, was aimed at supporting NHS-led health research into diagnostics and treatment through new privacy-preserving platforms and clinical research services, along with £60 million (US$63.60 million) to aid in expanding life sciences manufacturing in the UK. Consequently, the growth of government initiatives in healthcare is driving the immunoassay market.

A key trend gaining momentum is product innovation, with major companies striving to strengthen their market position through cutting-edge offerings. For instance, Getein Biotech Inc., a China-based biotechnological company, introduced the MAGICL 6000 at MEDICA 2022. This portable chemiluminescence immunoassay analyzer is designed for labs with mid- to high-workflow requirements, providing a one-step chemiluminescence solution. The instrument stands out for its efficiency, compact size, complete automation, and rapid assessment frequency, offering a technologically advanced option for diagnostic laboratories.

Major players in the immunoassay market are introducing innovative immunoassay analyzers to gain a competitive advantage. These analyzers automate the detection and quantification of biological molecules, such as proteins or hormones, through immunological reactions. Beckman Coulter Diagnostics launched the DxI 9000 Access Immunoassay Analyzer in May 2023, addressing the needs of clinical laboratories for speed, reliability, reproducibility, and expanded menu options. The analyzer incorporates advanced features such as new analyte processing and detection technology, precision sensors, smart algorithms, and remote real-time system monitoring. Its distinctive feature includes no daily maintenance, enhancing its efficiency in diagnostic workflows.

In January 2023, Heska Corporation, a US-based biotechnology firm, acquired MBio Diagnostics, Inc. for an undisclosed sum. This acquisition is intended to strengthen Heska Corporation's research, development, and manufacturing capabilities, primarily by incorporating LightDeck's innovative point-of-care technology. This integration will facilitate the launch of advanced diagnostic platforms, including a product for canine cancer screening. MBio Diagnostics, Inc. is a US-based company that specializes in immunoassays.

Major companies operating in the immunoassay market include Siemens Healthineers GmbH, bioMerieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.

North America was the largest region in the immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the immunoassay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The immunoassay market includes revenues earned by entities by supplying immunoassay kits, analyzers, and reagents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunoassay Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunoassay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunoassay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immunoassay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Reagents And Kits; Analyzers Or Instruments; Software And Services
• 2) By Specimen: Blood; Saliva; Urine; Other Specimens
• 3) By Application: Therapeutic Drug Monitoring; Oncology; Cardiology; Endocrinology; Infectious Disease Testing; Autoimmune Diseases; Other Applications
• 4) By End User: Research And Academic Laboratories; Home Care Settings; Pharmaceutical And Biotechnology Companies And CROs; Blood Banks; Hospitals And Clinics; Clinical Laboratories
• Subsegments:
• 1) By Reagents And Kits: ELISA Kits; Rapid Test Kits; Control Reagents; Assay Development Reagents
• 2) By Analyzers Or Instruments: Automated Analyzers; Point-Of-Care Testing Devices; Microplate Readers; Luminometers
• 3) By Software And Services: Data Management Software; Analytical Software; Support And Maintenance Services; Consulting Services
• Companies Mentioned: Siemens Healthineers GmbH; bioMerieux; Abbott; Beckman Coulter Inc.; Quidel Corporation; Ortho Clinical Diagnostics; Sysmex Corporation; Bio-Rad Laboratories Inc.; Becton Dickinson and Company; F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Merck KGaA; Agilent Technologies Inc.; PerkinElmer Inc; WAK-Chemie Medical GmbH; J Mitra & Co Pvt Ltd; Kamiya Biomedical Company; Tosoh Corporation; Gyros Protein Technologies AB; BioCheck Inc.; Bio-Techn; DiaSorin S.p.A; Meso Scale Diagnostics LLC; QIAGE; Randox Laboratories Ltd.; Shenzhen Mindray Bio-Medical Electronics Co Ltd; Danaher Corporation; Hologic Inc.; Tecan Trading AG; Eurofins Scientific; Abcam plc; Enzo Biochem Inc.; Luminex Corporation; Quanterix Corporation; Roche Diagnostics; ZEUS Scientific Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Immunoassay Market Characteristics

3. Immunoassay Market Trends And Strategies

4. Immunoassay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Immunoassay Growth Analysis And Strategic Analysis Framework

• 5.1. Global Immunoassay PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Immunoassay Market Growth Rate Analysis
• 5.4. Global Immunoassay Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Immunoassay Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Immunoassay Total Addressable Market (TAM)

6. Immunoassay Market Segmentation

• 6.1. Global Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Kits
• Analyzers Or Instruments
• Software And Services
• 6.2. Global Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood
• Saliva
• Urine
• Other Specimens
• 6.3. Global Immunoassay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutic Drug Monitoring
• Oncology
• Cardiology
• Endocrinology
• Infectious Disease Testing
• Autoimmune Diseases
• Other Applications
• 6.4. Global Immunoassay Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research And Academic Laboratories
• Home Care Settings
• Pharmaceutical And Biotechnology Companies And CROs
• Blood Banks
• Hospitals And Clinics
• Clinical Laboratories
• 6.5. Global Immunoassay Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• ELISA Kits
• Rapid Test Kits
• Control Reagents
• Assay Development Reagents
• Hospitals And Clinics
• 6.6. Global Immunoassay Market, Sub-Segmentation Of Analyzers Or Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automated Analyzers
• Point-Of-Care Testing Devices
• Microplate Readers
• Luminometers
• 6.7. Global Immunoassay Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Management Software
• Analytical Software
• Support And Maintenance Services
• Consulting Services

7. Immunoassay Market Regional And Country Analysis

• 7.1. Global Immunoassay Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Immunoassay Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunoassay Market

• 8.1. Asia-Pacific Immunoassay Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunoassay Market

• 9.1. China Immunoassay Market Overview
• 9.2. China Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunoassay Market

• 10.1. India Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunoassay Market

• 11.1. Japan Immunoassay Market Overview
• 11.2. Japan Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunoassay Market

• 12.1. Australia Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunoassay Market

• 13.1. Indonesia Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunoassay Market

• 14.1. South Korea Immunoassay Market Overview
• 14.2. South Korea Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunoassay Market

• 15.1. Western Europe Immunoassay Market Overview
• 15.2. Western Europe Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunoassay Market

• 16.1. UK Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunoassay Market

• 17.1. Germany Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunoassay Market

• 18.1. France Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunoassay Market

• 19.1. Italy Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunoassay Market

• 20.1. Spain Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunoassay Market

• 21.1. Eastern Europe Immunoassay Market Overview
• 21.2. Eastern Europe Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunoassay Market

• 22.1. Russia Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunoassay Market

• 23.1. North America Immunoassay Market Overview
• 23.2. North America Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunoassay Market

• 24.1. USA Immunoassay Market Overview
• 24.2. USA Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunoassay Market

• 25.1. Canada Immunoassay Market Overview
• 25.2. Canada Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunoassay Market

• 26.1. South America Immunoassay Market Overview
• 26.2. South America Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunoassay Market

• 27.1. Brazil Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunoassay Market

• 28.1. Middle East Immunoassay Market Overview
• 28.2. Middle East Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunoassay Market

• 29.1. Africa Immunoassay Market Overview
• 29.2. Africa Immunoassay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunoassay Market Competitive Landscape And Company Profiles

• 30.1. Immunoassay Market Competitive Landscape
• 30.2. Immunoassay Market Company Profiles
  • 30.2.1. Siemens Healthineers GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. bioMerieux Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Beckman Coulter Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Immunoassay Market Other Major And Innovative Companies

• 31.1. Ortho Clinical Diagnostics
• 31.2. Sysmex Corporation
• 31.3. Bio-Rad Laboratories Inc.
• 31.4. Becton Dickinson and Company
• 31.5. F. Hoffmann-La Roche Ltd
• 31.6. Thermo Fisher Scientific Inc.
• 31.7. Merck KGaA
• 31.8. Agilent Technologies Inc.
• 31.9. PerkinElmer Inc
• 31.10. WAK-Chemie Medical GmbH
• 31.11. J Mitra & Co Pvt Ltd
• 31.12. Kamiya Biomedical Company
• 31.13. Tosoh Corporation
• 31.14. Gyros Protein Technologies AB
• 31.15. BioCheck Inc.

32. Global Immunoassay Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunoassay Market

34. Recent Developments In The Immunoassay Market

35. Immunoassay Market High Potential Countries, Segments and Strategies

• 35.1 Immunoassay Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Immunoassay Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Immunoassay Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer